41 related articles for article (PubMed ID: 10388116)
21. Erythropoietin and chronic lymphocytic leukemia.
Mauro FR; Gentile M; Foa R
Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
[TBL] [Abstract][Full Text] [Related]
22. rHuEPO and improved treatment outcomes: potential modes of action.
Blackwell K; Gascón P; Sigounas G; Jolliffe L
Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
[TBL] [Abstract][Full Text] [Related]
23. The interaction between heart failure and other heart diseases, renal failure, and anemia.
Silverberg DS; Wexler D; Iaina A; Schwartz D
Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
[TBL] [Abstract][Full Text] [Related]
24. Iron supplementation in renal anemia.
Fishbane S
Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
[TBL] [Abstract][Full Text] [Related]
25. Anemia of chronic disease: pathophysiology and laboratory diagnosis.
Thomas C; Thomas L
Lab Hematol; 2005; 11(1):14-23. PubMed ID: 15790548
[TBL] [Abstract][Full Text] [Related]
26. Diagnosing and treating anemia and iron deficiency in hemodialysis patients.
Foret JP
Nephrol Nurs J; 2002 Jun; 29(3):292-6. PubMed ID: 12164080
[TBL] [Abstract][Full Text] [Related]
27. Current concepts of anemia management in chronic renal failure: impact of NKF-DOQI.
Eschbach JW
Semin Nephrol; 2000 Jul; 20(4):320-9. PubMed ID: 10928333
[TBL] [Abstract][Full Text] [Related]
28. [Pure red cell aplasia in erythropoietin therapy in patients with kidney failure].
Opatrný K
Cas Lek Cesk; 2003; 142(12):741-5. PubMed ID: 14746223
[TBL] [Abstract][Full Text] [Related]
29. [Pure red-cell anemia due to recombinant human erythropoietin and its status in oncology practice].
Lehoczky O
Magy Onkol; 2004; 48(2):163-6. PubMed ID: 15351813
[TBL] [Abstract][Full Text] [Related]
30. [Human recombinant erythropoietin therapy].
Donato H; Ferro H
Medicina (B Aires); 2006; 66(1):51-69. PubMed ID: 16555732
[TBL] [Abstract][Full Text] [Related]
31. Evaluating traditional iron measures and exploring new options for patients on hemodialysis.
Petroff S
Nephrol Nurs J; 2005; 32(1):65-73; quiz 74-5. PubMed ID: 15787086
[TBL] [Abstract][Full Text] [Related]
32. Anemia and chronic heart failure implications and treatment options.
Anand IS
J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
[TBL] [Abstract][Full Text] [Related]
33. Supplemental Iron: A Key to Optimizing the Response of Cancer-Related Anemia to rHuEPO?
Henry DH
Oncologist; 1998; 3(4):275-278. PubMed ID: 10388116
[TBL] [Abstract][Full Text] [Related]
34. Role of iron in optimizing responses of anemic cancer patients to erythropoietin.
Glaspy J; Cavill I
Oncology (Williston Park); 1999 Apr; 13(4):461-73; discussion 477-8, 483-8. PubMed ID: 10234700
[TBL] [Abstract][Full Text] [Related]
35. Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.
Beguin Y
Med Oncol; 1998 Aug; 15 Suppl 1():S38-46. PubMed ID: 9785336
[TBL] [Abstract][Full Text] [Related]
36. Managing erythropoietin hyporesponsiveness.
Kwack C; Balakrishnan VS
Semin Dial; 2006; 19(2):146-51. PubMed ID: 16551293
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
